Rain Therapeutics Inc. (RAIN) Event Aug. 04, 2022, 05:01 UTC 103 0 comments Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma Comment Full text
Cytokinetics Inc (CYTK) Event Aug. 04, 2022, 04:32 UTC 101 0 comments Cytokinetics and The ALS Association Announce Release of Updated PRO-ACT Database Including Data From Cytokinetics’ Completed ALS Clinical Trials Comment Full text
Passage Bio Inc. (PASG) Event Aug. 04, 2022, 04:04 UTC 104 0 comments Passage Bio, Inc. - Corporate Presentation - August 2022 Comment Full text
Lyell Immunopharma (LYEL) Event Aug. 04, 2022, 00:00 UTC 30 1 comments (42% Neutral) Lyell Immunopharma, Inc. (LYEL) Reports Profit for 2022-06-30 Comment Full text
Harvard Bioscience Inc (HBIO) Event Aug. 04, 2022, 00:00 UTC 56 1 comments (76% Positive) HARVARD BIOSCIENCE INC (HBIO) Reports 76% Loss Reduction for 2022-06-30 Comment Full text
Arcutis Biotherapeutics (ARQT) Event Aug. 04, 2022, 00:00 UTC 54 1 comments (75% Positive) ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Reports 41% Loss Reduction for 2022-06-30 Comment Full text
None (NSTG) Event Aug. 04, 2022, 00:00 UTC 47 1 comments (75% Positive) NANOSTRING TECHNOLOGIES, INC. (NSTG) Reports 30% Loss Reduction for 2022-06-30 Comment Full text
Guardant Health Inc (GH) Event Aug. 04, 2022, 00:00 UTC 47 1 comments (61% Neutral) GUARDANT HEALTH, INC. (GH) Reports Financial Results for 2022-06-30 Comment Full text
Sangamo Therapeutics Inc (SGMO) Event Aug. 04, 2022, 00:00 UTC 53 1 comments (51% Neutral) SANGAMO THERAPEUTICS, INC. (SGMO) Reports Financial Results for 2022-06-30 Comment Full text
Sana Biotechnology Inc (SANA) Event Aug. 04, 2022, 00:00 UTC 47 1 comments (28% Negative) Sana Biotechnology, Inc. (SANA) Reports 56% Loss Increase for 2022-06-30 Comment Full text